Skip Navigation
Skip to contents

KMJ : Kosin Medical Journal

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse articles > Author index
Search
Hong-Sik Shon 2 Articles
Remimazolam in pediatric surgery under general anesthesia: a case series
Hong-Sik Shon, Seyeon Park, Jung-Pil Yoon, Yeong Min Yoo, Jimin Lee, Da Eun Lee, Hee Young Kim
Kosin Med J. 2024;39(3):201-206.   Published online May 9, 2024
DOI: https://doi.org/10.7180/kmj.24.105
  • 1,027 View
  • 38 Download
  • 1 Citations
Abstract PDFPubReader   ePub   
Remimazolam is a promising drug for general anesthesia due to its rapid onset, short duration, and short context-sensitive half-life. However, its use in pediatric patients remains off-label, and limited prospective data have been published. Herein, we report successful anesthesia using remimazolam in pediatric patients who had a history of epilepsy or required shared airway surgery. In all cases, remimazolam provided general anesthesia, and flumazenil was used for reversal with rapid recovery. Remimazolam offers advantages for pediatric anesthesia in scenarios with a risk of seizure or shared airway surgery. However, the potential for higher bispectral index values and the risk of anaphylaxis in dextran-allergic patients necessitate caution and further research.

Citations

Citations to this article as recorded by  
  • Remimazolam: Is the new “wonder drug” in anesthesia any good in children?
    Tom G. Hansen, Thomas Engelhardt
    Acta Anaesthesiologica Scandinavica.2025;[Epub]     CrossRef
Total intravenous anesthesia using remimazolam for patients with heart failure with reduced ejection fraction: a case series
Jimin Lee, Ji-Uk Yoon, Gyeong-Jo Byeon, Hong-Sik Shon, Ahhyeon Yi, Hee Young Kim
Kosin Med J. 2024;39(2):144-149.   Published online May 9, 2024
DOI: https://doi.org/10.7180/kmj.23.156
  • 1,446 View
  • 32 Download
Abstract PDFPubReader   ePub   
Patients with heart failure undergoing surgery that requires general anesthesia face substantial perioperative risks; however, clear guidelines are not available for anesthesia management in patients with a reduced left ventricular ejection fraction. Traditional intravenous and volatile anesthetics require careful administration to prevent severe hypotension and bradycardia in patients with heart failure. Remimazolam has emerged as a promising alternative to conventional anesthetics because of its reduced cardiovascular depressive effects. We present three cases illustrating the successful use of remimazolam to induce and maintain general anesthesia in patients with heart failure and reduced cardiac function. Our cases demonstrate the safe use of remimazolam for general anesthesia in patients with heart failure and a reduced ejection fraction.

KMJ : Kosin Medical Journal
TOP